Protara Therapeutics (TARA) Total Non-Current Liabilities (2013 - 2016)
Protara Therapeutics (TARA) posted quarterly Total Non-Current Liabilities of $4.8 million for Q3 2016, up 52.9% year-over-year from $3.2 million in Q4 2015, and up 7.72% quarter-over-quarter from $4.5 million in Q2 2016.
Protara Therapeutics (TARA) Total Non-Current Liabilities (2013 - 2016) Analysis & Trends
Protara Therapeutics (TARA) has reported Total Non-Current Liabilities for 4 consecutive years, with $4.8 million the latest figure, recorded in Q3 2016.
- In Q3 2016, Total Non-Current Liabilities rose 52.9% year-over-year to $4.8 million; the TTM figure through Sep 2016 stood at $4.8 million (up 52.9% YoY), while the FY2015 annual figure was $3.6 million, changed N/A from the prior year.
- Total Non-Current Liabilities climbed to $4.8 million in Q3 2016 per TARA's latest filing, from $4.5 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $8.3 million in Q4 2013 and bottomed at $2.7 million in Q3 2014.
- Historically, Total Non-Current Liabilities has averaged $4.1 million across 4 years, with a median of $3.4 million in 2015.
- Annual changes were most pronounced in 2015 — Total Non-Current Liabilities rose 19.19% — and 2016, when it surged 62.64%.
- Protara Therapeutics' Total Non-Current Liabilities stood at $8.3 million in 2013, then sank by 68.07% to $2.7 million in 2014, then soared by 35.29% to $3.6 million in 2015, then jumped by 34.71% to $4.8 million in 2016.
- Business Quant data shows TARA's Total Non-Current Liabilities at $4.8 million in Q3 2016, $4.5 million in Q2 2016, and $3.3 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.92 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 7.74 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 40.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.53 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.88 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.32 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.17 Bn |
| 10 | Protara Therapeutics | 234.56 Mn | 234.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 4.84 Mn |
| Jun 30, 2016 | 4.50 Mn |
| Mar 31, 2016 | 3.27 Mn |
| Dec 31, 2015 | 3.60 Mn |
| Sep 30, 2015 | 3.17 Mn |
| Jun 30, 2015 | 2.77 Mn |
| Sep 30, 2014 | 2.66 Mn |
| Dec 31, 2013 | 8.33 Mn |